Please assess the completion status of the following clinical trial:

Trial Title: Risk Stratification Procedure for Thromboembolism Prophylaxis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or Female patients who are planned for elective TKR surgery (primary only).~2. Agreed to sign the Informed consent form (ICF).~3. Patients aged older than 18 years.~Exclusion Criteria:~1. Patients receiving anticoagulant for treatment.~2. Patients with a history of DVT or PE were excluded from the study due to the marked increase in the risk of recurrent VTE compared to the general risk of (7% vs. 0.1%); (Fahrni, 2015).~3. Patients with renal or hepatic failure, renal failure is defined as end-stage kidney disease (on dialysis); hepatic failure is defined as complete liver cirrhosis.~4. Pregnant woman.~5. Revision surgeries.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): In this group a VTE risk stratification procedure will be used
- Group B (Type: NO_INTERVENTION): In this group a standard VTE risk stratification procedure will be used (Caprini VTE risk assessment tool)

Based on this trial design, predict the completion outcome and termination type (if applicable).